Abstract
Coagulation factor XIII (FXIII) covalently crosslinks pre-formed fibrin clots preventing their premature fibrinolysis. In plasma, FXIII circulates as a zymogenic heterotetramer composed of catalytic FXIII-A subunits, and carrier/regulatory FXIII-B subunits. FXIII-A is a well characterized component of this complex, and has been associated with several pleiotropic roles outside coagulation as well. In comparison only protective/regulatory roles towards the FXIII-A subunit have been identified for FXIII-B. Strong homology between FXIII-B and complement regulator Complement factor H suggests a putative role of FXIII-B in complement activation. In the current study we have analyzed the similarities and yet functional divergence of these two proteins using in silico sequence alignment and structural analysis. We have evaluated complement activation post reconstitution of FXIII components into FXIII deficient and CFH deficient plasma. We have also transiently expressed FXIII-B in SH-SY5Y cell lines and evaluated its effect on the endogenous complement activation. Our investigations show no effect of FXIII-B subunit on the rate of complement activation. Therefore we conclude that at a physiological level, FXIII-B subunit plays no role in the complement system, although a vestigial function in altered pathological states might still exist.
Similar content being viewed by others
References
Amara U, Flierl MA, Rittirsch D et al (2010) Molecular intercommunication between the complement and coagulation systems. J Immunol 185(9):5628–5636. https://doi.org/10.4049/jimmunol.0903678
Esmon CT (2004) The impact of the inflammatory response on coagulation. Thromb Res 114(5–6):321–327. https://doi.org/10.1016/j.thromres.2004.06.028
Krisinger MJ, Goebeler V, Lu Z et al (2012) Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway. Blood 120(8):1717–1725. https://doi.org/10.1182/blood-2012-02-412080
Foley JH, Walton BL, Aleman MM et al (2016) Complement activation in arterial and venous thrombosis is mediated by plasmin. EBioMedicine 5:175–182. https://doi.org/10.1016/j.ebiom.2016.02.011
Markiewski MM, DeAngelis RA, Lambris JD (2008) Complexity of complement activation in sepsis. J Cell Mol Med 12(6a):2245–2254. https://doi.org/10.1111/j.1582-4934.2008.00504.x
Jenny L, Dobó J, Gál P et al (2018) MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model. PLoS ONE 13(1):e0191292. https://doi.org/10.1371/journal.pone.0191292
Adamiak M, Abdelbaset-Ismail A, Suszynska M et al (2017) Novel evidence that the mannan-binding lectin pathway of complement activation plays a pivotal role in triggering mobilization of hematopoietic stem/progenitor cells by activation of both the complement and coagulation cascades. Leukemia 31(1):262–265. https://doi.org/10.1038/leu.2016.278
Gupta S, Biswas A, Akhter MS et al (2016) Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective. Sci Rep 6(1):245. https://doi.org/10.1038/srep30105
Biswas A, Thomas A, Bevans CG et al (2013) In vitro secretion deficits are common among human coagulation factor XIII subunit B missense mutants. Correlations with patient phenotypes and molecular models. Human Mutation 34(11):1490–1500. https://doi.org/10.1002/humu.22391
Thomas A, Biswas A, Ivaskevicius V et al (2015) Structural and functional influences of coagulation factor XIII subunit B heterozygous missense mutants. Mol Genet Genomic Med 3(4):258–271. https://doi.org/10.1002/mgg3.138
Schroeder V, Kohler H (2016) Factor XIII: structure and function. Semin Thromb Hemost 42(04):422–428. https://doi.org/10.1055/s-0036-1571341
Souri M, Kaetsu H, Ichinose A (2008) Sushi domains in the B subunit of factor XIII responsible for oligomer assembly. Biochemistry 47(33):8656–8664. https://doi.org/10.1021/bi8006143
Mezei ZA, Katona É, Kállai J et al (2017) Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism. Thromb Res 158:93–97. https://doi.org/10.1016/j.thromres.2017.08.018
Pitkänen HH, Jouppila A, Lemponen M et al (2017) Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement. Thromb Res 149:56–61. https://doi.org/10.1016/j.thromres.2016.11.012
Deicke C, Chakrakodi B, Pils MC et al (2016) Local activation of coagulation factor XIII reduces systemic complications and improves the survival of mice after Streptococcus pyogenes M1 skin infection. Int J Med Microbiol 306(7):572–579. https://doi.org/10.1016/j.ijmm.2016.06.001
Orosz ZZ, Katona É, Facskó A et al (2011) Factor XIII subunits in human tears; their highly elevated levels following penetrating keratoplasty. Clin Chim Acta 412(3–4):271–276. https://doi.org/10.1016/j.cca.2010.10.017
Ariëns RA, Kohler HP, Mansfield MW et al (1999) Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscl Thromb Vasc Biol 19(8):2012–2016
Kopp A, Hebecker M, Svobodova E et al (2012) Factor H. A complement regulator in health and disease, and a mediator of cellular interactions. Biomolecules 2(1):46–75. https://doi.org/10.3390/biom2010046
Rodriguez de Cordoba S, Rey-Campos J, Dykes DD et al (1988) Coagulation factor XIII B subunit is encoded by a gene linked to the regulator of complement activation (RCA) gene cluster in man. Immunogenetics 28(6):452–454
Fagerberg L, Hallström BM, Oksvold P et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Prot 13(2):397–406. https://doi.org/10.1074/mcp.M113.035600
Simon Á, Bagoly Z, Hevessy Z et al (2012) Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia. Cytometry 82B(4):209–216. https://doi.org/10.1002/cyto.b.21019
Thomas A, Gasque P, Vaudry D et al (2000) Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol 12(7):1015–1023
Okemefuna AI, Nan R, Gor J et al (2009) Electrostatic Interactions Contribute to the Folded-back Conformation of Wild Type Human Factor H. J Mol Biol 391(1):98–118. https://doi.org/10.1016/j.jmb.2009.06.010
Aslam M, Perkins SJ (2001) Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J Mol Biol 309(5):1117–1138. https://doi.org/10.1006/jmbi.2001.4720
Moore BL, Kelley LA, Barber J et al (2013) High-quality protein backbone reconstruction from alpha carbons using Gaussian mixture models. J Comput Chem 34(22):1881–1889. https://doi.org/10.1002/jcc.23330
Xu D, Jaroszewski L, Li Z et al (2014) AIDA: ab initio domain assembly server. Nucleic Acids Res 42(W1):W308–W313. https://doi.org/10.1093/nar/gku369
Krieger E, Koraimann G, Vriend G (2002) Increasing the precision of comparative models with YASARA NOVA—a self-parameterizing force field. Proteins 47(3):393–402
Krieger E, Vriend G (2014) YASARA View: molecular graphics for all devices—from smartphones to workstations. Bioinformatics 30(20):2981–2982. https://doi.org/10.1093/bioinformatics/btu426
Katona E, Haramura G, Kárpáti L et al (2000) A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2). Thromb Haemost 83(2):268–273
Katona EE, Ajzner E, Toth K et al (2001) Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates. J Immunol Methods 258(1–2):127–135
Lee KN, Birckbichler PJ, Patterson MK, JR (1988) Colorimetric assay of blood coagulation factor XIII in plasma. Clin Chem 34(5):906–910
Krushkal J, Bat O, Gigli I (2000) Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster. Mol Biol Evol 17(11):1718–1730. https://doi.org/10.1093/oxfordjournals.molbev.a026270
Reid KBM, Bentley DR, Campbell RD et al (1986) Complement system proteins which interact with C3b or C4b A superfamily of structurally related proteins. Immunol Today 7(7–8):230–234. https://doi.org/10.1016/0167-5699(86)90110-6
Müller-Calleja N, Ritter S, Hollerbach A et al (2018) Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies. Blood Adv 2(9):979–986. https://doi.org/10.1182/bloodadvances.2018017095
Skjeflo EW, Christiansen D, Fure H et al (2018) Staphylococcus aureus-induced complement activation promotes tissue factor-mediated coagulation. J Thromb Haemost 16(5):905–918. https://doi.org/10.1111/jth.13979
Subramaniam S, Jurk K, Hobohm L et al (2017) Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood 129(16):2291–2302. https://doi.org/10.1182/blood-2016-11-749879
Scheetz TE, Fingert JH, Wang K et al (2013) A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel loci. PLoS ONE 8(3):e58657. https://doi.org/10.1371/journal.pone.0058657
Hageman GS, Gehrs K, Lejnine S et al (2011) Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration. Human Genom 5(5):420–440
Schwartz ML, Pizzo SV, Hill RL et al (1973) Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem 248(4):1395–1407
Author information
Authors and Affiliations
Contributions
AB and JO are the principle investigators of the study. MSA and SS performed the laboratory experiments. MSA, SS and AB analyzed the data, generated the images and co-wrote the article. AB, HY, VI and JO edited and revised the article. AB designed the study. None of the authors have any conflict of interest in the following work. The authors would like to acknowledge technical help from Sophie Lyonga.
Corresponding author
Ethics declarations
Conflict of interest
Authors declare no conflict of interest.
Ethical approval
This article does not contain any studies with animals performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Akhter, M.S., Singh, S., Yadegari, H. et al. Exploring the structural similarity yet functional distinction between coagulation factor XIII-B and complement factor H sushi domains. J Thromb Thrombolysis 48, 95–102 (2019). https://doi.org/10.1007/s11239-019-01841-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-019-01841-w